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Introduction
Migraine is a common, chronic, disabling condition characterized by recurrent episodes of headache accompanied by debilitation, nausea, vomiting, photophobia, and phonophobia. Estimations show that approximately 12% of adults in the United States suffer from migraines. 1, 2 Evidence in this area suggests that migraine is not well managed in primary care, with only about 50% of migraineurs consulting their physician concerning this condition. [2] [3] [4] Physicians incorrectly diagnose 50% of migraineurs, and many patients who are correctly diagnosed receive sub-optimal treatment, making migraine an underdiagnosed and undertreated condition. 3, [5] [6] [7] [8] Because of this, some patients
In addition, the majority of migraine sufferers are not satisfied with their current therapy. 7 These trends suggest that pharmacists may be in an ideal position to improve migraineur outcomes through providing headache sufferer triage, pharmacologic and non-pharmacologic treatment recommendations, and patient counseling.
Appropriate education is necessary for healthcare professionals to successfully manage disease states.
Pharmacists who have completed a training program in pharmaceutical care with an emphasis on pain have been shown to make a positive impact on headache and migraine sufferers' mental health and self-efficacy. 14 Ideally, all healthcare professionals, including pharmacists, who come in contact with recurrent headache sufferers should be educated on migraine identification and treatment approaches. As very accessible healthcare professionals with extensive knowledge and training, community pharmacists are in an ideal position to combat recurrent headache sufferer underconsulting, underdiagnosis, and undertreatment. Even though community pharmacists possess the tools necessary to make a positive impact on chronic headache sufferers, many of them are not well versed in migraine identification or current migraine treatment guidelines. 15 An educational intervention in the form of a continuing education (CE) program is a good option to allow pharmacists a chance to practice their skills in working with recurrent headache sufferers.
The Pharmacists' Care of Migraineurs Scale (PCMS), a valid and reliable instrument, was developed as a tool for documenting pharmacists' care of migraine sufferers and identifying factors associated with the quality of the care provided. 16 Pharmacists' self-reported knowledge of migraine was found to be a key factor and accounted for 38% of the variance in responses in the PCMS. 17 The areas of the instrument used in the PCMS study that addressed selfassessed knowledge of migraine were multi-faceted and included treatment guidelines, non-pharmacologic management of migraine, abortive and preventative pharmacologic therapies, as well as prescription drug therapy formulary issues and costs of oral triptan therapies. 16, 17 In this study, the researchers hypothesized that pharmacists with additional and comprehensive education targeting migraineur care, delivered as a CE program, would report improved migraine knowledge and provide higher quality care to migraine sufferers. Consequently, these pharmacists may be able to positively impact chronic headache sufferers' outcomes. The researchers also hypothesize that no difference will be seen with regard to the educational intervention and any independent variables, such as sex, age, or history of migraine headaches.
Objectives
The objectives of this study were to: (1) Compare pharmacists' self-assessed knowledge of migraine before and after an educational intervention; (2) Compare pharmacists' self-reported care behaviors following an educational intervention with a control group of pharmacists; (3) Identify inter-and intra-group interactions between the educational intervention results and various individual independent variables.
Methods

Sample population/recruitment
The sample was selected from a regional chain of community pharmacies located in northeastern Oklahoma.
Pharmacists were eligible for inclusion if they were a current pharmacist at one of 20 community pharmacies in the regional chain and if they had an active and in good standing Oklahoma pharmacy license. Excluded from the study were relief pharmacists and those who failed to complete the surveys.
The pharmacists were made aware of the educational program through direct recruitment, fliers, and emails. If pharmacists in a given location were interested in participating in the educational program, all pharmacists from that store were assigned to the intervention group. Conversely, if the pharmacists for that location were neither interested nor able to participate in the intervention, they were asked to participate in the control group. Individual pharmacies were selected based on convenience and geographic proximity to where the educational program would be held. A replacement strategy using store proximity was used to reach the desired sample size of 10 pharmacies in both the intervention and control groups. Based on estimates from the pharmacy chain's upper management, the researchers expected approximately 2.5 pharmacists per store and thus a sample size of 25 pharmacists in each group.
Approval for the project was obtained from the University's institutional review board. Informed consent was obtained from all project participants.
Research design and procedures
This study used a quasi-experimental, parallel design. Questionnaires gathering demographic and migraine specific information were administered to the intervention group of pharmacists at baseline just prior to their participation in a two-hour educational course on migraines. One month following the educational program, the same pharmacists
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were hand-delivered and asked to complete the same questionnaire within a two-week time frame. Pharmacists in the control group completed their only questionnaire at the same time the intervention pharmacists completed their follow-up.
Not all pharmacists in a store were available to attend an educational program at the same time, so the program was offered live on two separate dates and pre-recorded online. Pharmacists who were unable to attend either of the live programs were supplied with the baseline questionnaire, allowed time to fill it out, and provided a link to the online program. When the program was complete, the pharmacist was asked to submit assessment question responses to the educational program administrators to prove completion (and to confer CE credits). At one month from educational program completion, the second questionnaire was delivered and the pharmacist was allowed two weeks to complete and return it.
Surveys were stamped with a numeric code known only to a participating research assistant. The research assistant had the ability to link survey questionnaire responses to individual respondents; however, this information was protected and precluded from disclosure to or use by the investigators.
The intervention consisted of an Accreditation Council for Pharmacy Education (ACPE)-approved CE program given at the University of Oklahoma Health Sciences Center, Tulsa Campus on March 6 and 7, 2010. The program was primarily didactic and covered migraine pathophysiology, screening headache patients, migraine triggers, pharmacotherapy for treatment and prevention of migraines, and nonpharmacologic recommendations for migraineurs. The program contained pharmacotherapy pearls important for a community pharmacist, and it also mirrored the many facets of the PCMS tool the investigators used for data collection. Active learning components (e.g., case studies to strengthen knowledge retention and flowcharts for acute and preventive migraine therapy selections) were incorporated to strengthen recommendation clarifications for the intervention group pharmacists. The pharmacist leading the sessions was a migraine expert who works with migraine patients on a daily basis and has substantial experience delivering migraine educational programs.
Pharmacists who participated in the educational program received a meal during the program, two hours of CE credit, and a $50 gift card. Pharmacists in both the intervention and control groups received $5 gift cards when the surveys were delivered one month after the program was held.
Instruments
Demographic information considered to be potentially associated with the outcomes of interest was gathered for each participating pharmacist. Information gathered included gender, age, years as a community pharmacist, years with current employer, and presence/absence of migraines.
The PCMS 16 , a validated survey used to assess self-reported care behaviors, is divided into 6 different parts: (1) perceived difficulty in providing care to recurrent headache sufferers, (2) perceived self-efficacy or level of confidence in providing care to recurring headache sufferers, (3) employer culture, (4) self-assessed knowledge of migraine, (5) actual care provided to recurring headache sufferers, and (6) ability to maintain knowledge of migraine. Each part of the PCMS was included in the survey provided to intervention and control group pharmacists, and the scales of assessment are described below.
Part one, perceived difficulty, and part two, perceived selfefficacy or level of confidence, were each assessed using 9 items measured on a 7-point Likert-type 18 scale of agreement. Parts one and two are related but unique components of perceived behavioral control, part of the theory of planned behavior and demonstrate importance in predicting pharmacists' job performance behaviors. 19 Perceived organizational culture, part three, is measured with 3 items using a semantic differential scale anchored with patient and product for orientation, quality and quantity for focus, and professional and technical for pharmacists' work. 20 Part four, self-assessed knowledge of migraine, is measured using 12 items on a 5-point Likert-type scale of agreement. Parts five and six comprise the previously validated PCMS portion of the questionnaire. The PCMS is a 41-item instrument measuring seven unique domains of pharmacists' care provided to recurrent headache sufferers, including: empathy, prospective drug utilization review (DUR) of newly diagnosed migraineurs, medication counseling, nonpharmacologic treatment plan, headache sufferer triage, dissemination of public health information, and maintenance of migraine knowledge.
Data analysis
Internal consistency reliability of the overall multiple-item multiple-scale survey instrument and each individual part of the survey was assessed using Cronbach's alpha (α). A Cronbach's alpha of 0.7 or higher is generally viewed as indicating acceptable reliability, but in the case of exploratory studies, 0.6 or higher is considered acceptable. 21 An a priori power analysis was completed, and it was determined a sample size of 25 pharmacists per group would be sufficient to detect a 10 point difference in score with 80% power, using an unpaired t-test with an alpha level of 0.05. Descriptive statistics were produced to quantify sociodemographic characteristics of the participants collectively and by group. Associations between variables were explored using unpaired t-tests, Mann-Whitney U, chi-square, or Fisher's exact tests, as appropriate. Intervention pharmacists' pre-education knowledge scores, part four, were compared to the post-education knowledge scores from the same group of pharmacists using a paired t-test. Parts five and six were separately tabulated from intervention group pre-and posteducation surveys and a Student's t-test was used to compare them to scores tabulated from control group surveys. Parts one, two, and three of the survey were handled in the same manner as parts five and six, including tabulations and comparisons. Additionally, scores were tabulated separately for each part of the survey and correlation coefficients were produced for each pairwise comparison in order to identify any potential associations between the sections. All analyses were performed using SAS v9.3 (SAS Institute, Cary, NC) with an alpha level of 0.05.
Results
Patient demographics
A total of 49 pharmacists were included in the study, with 24 in the intervention group and 25 in the control group. All pharmacists enrolled completed the study. Additional demographics and population characteristics are summarized in Table 1 .
Self-assessed knowledge of migraine
The first objective of the study was to compare pharmacists' self-assessed knowledge of migraine before and after an educational intervention addressing migraine identification and treatment. All 24 pharmacists assigned to the intervention group participated in the educational program and completed the required surveys. There was a significant increase between pre-and post-intervention scores on 10 of the 12 items related to knowledge, most notably, nonpharmacologic management of acute headaches, the role of complementary and alternative therapies in the treatment of migraine, the role of prescription drugs in migraine prophylaxis, distinguishing migraine from other types of headache, and formulary status of various migraine treatments. (Table 2) In addition, average post-intervention cumulative knowledge score (43.8) was significantly higher than that of pre-intervention (34.4), with the postintervention survey an average 9.4 points higher than the pre-intervention survey (p<0.0001).
Pharmacists in the intervention group showed no significant difference in pre-and post-intervention responses to items regarding knowledge of the role of prescription drugs in acute migraine therapy and knowledge of the cost to patients of various migraine treatment modalities (p=0.08 and p=0.41, respectively).
Self-reported care behaviors and ability to maintain knowledge of migraine (PCMS)
The second objective of the study was to compare selfreported care behaviors from a post-education survey of pharmacists to a group of control pharmacists. While there was no difference in average cumulative score between preeducation intervention pharmacists and control pharmacists (p=0.34), the mean post-education score of intervention pharmacists was 18.9 points higher than that of control pharmacists (p=0.004). (Table 3) When caring for recurrent headache sufferers, survey part five, pharmacists showed no difference in empathic responses when comparing the control and intervention groups. Pharmacists in the intervention group who were trained on triaging patients with possible migraines did score higher when asked about screening for drug-drug interactions and potential drug-related problems when filling a new migraine prescription (p=0.002 and p=0.03, respectively).
Pharmacists who underwent the educational program were more likely to enlist family support (p=0.03), determine if a headache was a migraine (p=0.02), educate staff to alert the pharmacist when a headache sufferer presented to the pharmacy counter (p<0.0001), and conduct a medication history for a migraineur (p=0.002). Pharmacists also reported higher scores with regard to medication counseling, developing a nonpharmacologic treatment plan such as using a migraine diary, discussing trigger management and the role of complementary and alternative medications. (Table 3) Part six of the survey addressed ability to maintain knowledge of migraine. The comparison between the average cumulative score of the post-educational survey taken by intervention pharmacists and the average cumulative score of control pharmacists showed that the intervention pharmacists had an average score that was 2.0 points higher than the control pharmacists (p=0.04). Pharmacists in the intervention group were more likely to attend live CE programming on migraines (p=0.04) and seek information on the internet regarding migraine headaches (p=0.04). (Table 4 Item deletions failed to result in any substantial improvement in reliability. The study design did not include multiple administrations of the instrument for data collection to be used in an analysis of test-retest reliability and the intervention and control group means were not available to test validity beyond face validity (110.4 versus 91.5, respectively). (Table 3 )
Analysis of correlation and interaction
Correlation matrices were produced for each survey administered examining potential relationships between survey sections and the independent variables age, gender, years as a community pharmacist, years with current employer and history of migraines. No correlations were found when analyzing control group surveys (n=25). A moderate positive correlation (p=0.04, p=0.05) between selfreported care behaviors and age was found in both the preand post-education surveys administered to the intervention group (n=24). Further investigation identified no associations between age and the remaining demographic variables and confirmed no significant change in comparison of outcomes of interest related to age. The individual location of each pharmacist was not considered to be a variable of interest during the design phase of the study and was not documented during data collection; therefore no analysis of potential within store correlation was performed. No significant interactions were found between the educational intervention and the demographic variables age, gender, years as a community pharmacist, years with current employer, or history of migraine headaches. Interestingly, however, pharmacists did not show a gain in knowledge regarding the role of acute therapies for migraine and the cost of such therapies. The researchers hypothesized pharmacists in the intervention group gained no additional knowledge about these topics compared to the control group pharmacists since acute migraine therapies are a common focus for pharmacy school curricula 22 and no research is available on if colleges of pharmacy teach the costs of these more expensive therapies (e.g. triptans), which could explain this lack of significance. Cost of medications was not a focus of the educational program presented. Conversely, it can be postulated that the control pharmacists may have had a better understanding of these components of migraine therapy.
Discussion
The care of a migraineur is more complicated than simply what medication to prescribe. Pharmacists who gain knowledge gain one of the many tools necessary to positively impact care of patients who suffer from chronic diseases such as migraine. It is important to note that just improving knowledge does not always translate into improving pharmacy practice activities. A study by Maio et al. evaluating the effectiveness of pharmacy CE programs showed that symposium-type programs were the most effective at enhancing knowledge. The results also showed that despite all programs being effective, no CE format was effective in helping pharmacists change clinical practice behaviors. 23 A program that successfully changes practice behaviors should consist of a variety of CE formats, including but not limited to didactic teaching, reading and handouts, hands-on activities and practice. The program developed for this project contained all of these elements, supporting the positive results seen post-intervention on the pharmacists' care behaviors.
In order to put into use the knowledge gained in an educational program, a pharmacist must not perceive the task to be too difficult and have confidence in their abilities to properly care for a patient. An educational program helps teach a pharmacist the knowledge needed, but confidence in applying the knowledge to a patient cannot be assumed simply by learning the material. The study population showed that the groups of pharmacists did not differ in the perceived difficulty in providing care to patients who suffer from migraines; however, the intervention pharmacists did show an increase in confidence to provide such care to patients post-intervention. Although pharmacists did not find providing this care difficult, many lacked the confidence to actually approach the care of a migraineur until this educational program. This program demonstrated positive outcomes to help eliminate barriers for pharmacists. Armed and provided with specific knowledge about migraine management, the researchers theorized these pharmacists will put into practice what they have learned about the management and care of this patient population.
The culture of the employer group is an important facet to providing care to patients. It can be presumed that if a pharmacist feels more supported to leave the pharmacy to discuss headache treatments with a recurrent headache sufferer, he/she will be more likely to do so. The results of the organizational culture questions showed that the groups viewed the organization similarly in the aspects of orientation, focus, and pharmacists' work priority, thus minimizing the chance that the intervention pharmacists viewed their culture differently than the control pharmacists.
After knowledge, confidence, perceived difficulty, and employer culture were assessed, the next step was to look into the actual care provided to recurrent headache sufferers.
The PCMS results showed that pharmacists in the intervention group scored cumulatively higher in the categories of actual care provided to recurrent headache sufferers, which were broken down into the factors of empathy, prospective DUR, headache sufferer triage, medication counseling, nonpharmacologic treatment plan, dissemination of public health information, and maintenance of knowledge on migraine. Pharmacists reported screening for drug-drug interactions and other drug-related problems more often in this population, possibly because these interactions were highlighted in the educational program. Patient triage was also highlighted in the educational program, including a quick 3-question screening tool called the ID-Migraine that a community pharmacist could use daily when a patient presents to the pharmacy counter with a headache. 24 This was discussed as something simple and not time-consuming a community pharmacist can do to change their clinical practice behaviors and get headache sufferers thinking more about what type of headache they may be having. The program also raised awareness of the importance of having staff alert the pharmacists if someone presents to the counter with a complaint of headache, another intervention highlighted in the educational program. Counseling practices improved for the intervention group as well, along with the nonpharmacologic recommendations for a person suffering with recurrent headache like keeping a headache diary, avoiding triggers, and the role that OTC medications play in prevention and management of migraine. 
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educational intervention the participants were expected to demonstrate more post-presentation knowledge than prior to the program. One month after the program the knowledge and practices learned were still being employed. The educational intervention and the post-surveys were spaced by one month to evaluate whether short-term retention of migraine knowledge and clinical practice skills were present. The results revealed retention did occur up to this one-month mark. This showed that one month after an educational intervention, pharmacists provide care to headache sufferers at a higher level than those that did not attend an educational programming on migraine headaches.
Limitations
Quasi-experimental research has limitations, including not being able to truly control for confounders. 25 The researchers controlled for confounders by group randomization of pharmacies, and also by excluding pharmacists who worked at multiple locations, thus attempting to eliminate the chance of knowledge from the CE program traveling from intervention store to control pharmacists.
Although the research had enough power to detect a significant difference between groups, the sample size was still small. Because of the groups' sizes, this study can serve as the pilot for a larger scale study to further define the impact of such an intervention for community pharmacists.
The results of this study may only be applicable to the population in which the intervention was conducted, which was a regional community pharmacy chain in northeastern Oklahoma. In addition, the convenience sampling may not be truly representative of the general population of pharmacists even in this area. Two elements of the study design may have allowed for the introduction of selection bias into the study. First, by basing group assignment on pharmacist preference rather than random placement, it is possible that the intervention group was composed of pharmacists who were more motivated than pharmacists in the control group. Second, the incentives offered for participation, although viewed as a potential means of partially correcting nonresponse bias, may have influenced individual inclination toward participation or non-participation. Also, the researchers relied on pharmacists to self-report behaviors, which have the potential to be inflated in the intervention group, introducing self-reporting bias into the results.
Contamination bias is a potential concern when conducting an educational intervention study comparing intervention and control groups. This study involved an inherent opportunity for pharmacists in the intervention group to share knowledge acquired at the educational course on migraines with pharmacists in the control group, potentially decreasing the difference between the groups and resulting in a loss of study validity. In order to control for this, it was necessary to minimize contact between pharmacists in the two groups in the work environment. This was accomplished by assigning all pharmacists from a single location to only one of the two groups and excluding from participation any pharmacist reasonably expected to work at more than one of the pharmacies during the course of the study, although complete protection from contamination bias was not guaranteed with this method.
The educational intervention was offered twice, but the sections occurred on a Saturday and Sunday of the same weekend. This could have posed an attendance issue since it is a common practice for community pharmacists scheduled to work on a given weekend to work both days. For those who were unable to attend a recording of the educational program was made available online, and it is possible that the study results were skewed due to differences in individual learning styles and availability for attendance at live educational sessions. Also, those that participated in the online viewing of the program may have been able to confer with colleagues that already attended the program live or completed it online to ask for help with assessment questions.
Future Directions
Recreating this study can help substantiate the impact seen, not only increasing enrollment but also studying more diverse populations of pharmacists of multiple states, employers, and disciplines (e.g. community pharmacy, ambulatory care, health-systems pharmacists). Future studies should also determine long-term effects of the educational intervention on the actual care provided by pharmacists for recurrent headache sufferers, evaluating continuing positive effect of the intervention after a year or longer. Moreover, future research should focus on data gathered from migraineurs about their perceptions of the care received from pharmacists trained in headache and migraine management. Valuable insights might also be achieved by evaluating outcomes based on intervention delivery method used.
Conclusion
Attending an educational program on migraine improved pharmacists' knowledge, confidence, and clinical practice behaviors when providing care to migraineurs and recurrent headache sufferers. This study demonstrated that focused educational initiatives increased patient counseling activities in the cohort of pharmacists participating in the initiative and caring behaviors toward the migraineur population. 
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Original Research I discuss non-pharmacologic adjunctive therapies for migraine attacks (heat, cold, relaxation techniques, rest, etc.) with migraine patients. Identify any adverse effects or other drugrelated problems associated with patients' migraine therapy. I look for signs that migraine therapy is not as effective as it could be (e.g., frequent use of OTC or prescription analgesics and triptans). I look for signs of non-adherence to migraine prophylaxis (e.g., late refills, increased migraine frequency and severity). I contact the prescriber to discuss alternatives or prophylaxis when acute migraine therapy is insufficient or ineffective (e.g., triptan is not working, patient uses triptan frequently, migraines particularly severe and long in duration). Contact prescriber if patients' prescribed therapy is not covered by insurance or whose cost may contribute to noncompliance. Gather a history of a consulting patient's recurring headache problem who has not yet seen a physician for the headache and make a referral, if necessary. Attempt to determine the nature of a consulting patient's headache to determine whether it is migraine, or some other type of headache. Refer a patient with a diagnosed, but unmanaged headache problem to a specialist (e.g., neurologist). 
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